SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022590
Filing Date
2022-11-07
Accepted
2022-11-07 16:06:39
Documents
73
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rvmd-20220930.htm   iXBRL 10-Q 3883187
2 EX-31.1 rvmd-ex31_1.htm EX-31.1 21284
3 EX-31.2 rvmd-ex31_2.htm EX-31.2 21229
4 EX-32.1 rvmd-ex32_1.htm EX-32.1 10975
5 EX-32.2 rvmd-ex32_2.htm EX-32.2 10965
  Complete submission text file 0000950170-22-022590.txt   12068428

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvmd-20220930_pre.xml EX-101.PRE 340620
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvmd-20220930_cal.xml EX-101.CAL 53980
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvmd-20220930.xsd EX-101.SCH 58389
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvmd-20220930_def.xml EX-101.DEF 190812
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvmd-20220930_lab.xml EX-101.LAB 465610
67 EXTRACTED XBRL INSTANCE DOCUMENT rvmd-20220930_htm.xml XML 2522592
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39219 | Film No.: 221365423
SIC: 2836 Biological Products, (No Diagnostic Substances)